IGEA Pharma NV - ESG Rating & Company Profile powered by AI
Alternative corporations in the scoring industry group for IGEA Pharma NV are shown below. Browse to the end of the webpage for potential risks for IGEA Pharma NV based on sector, geography and marketcap. The ESG assessment for IGEA Pharma NV represents the company's reporting of the UN SDGs.
IGEA Pharma NV in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 4.0, social score of 2.7 and governance score of 5.3.
4.0
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
201 | Paul Hartmann AG | 4.1 | High |
201 | Conformis Inc | 4.1 | High |
206 | IGEA Pharma NV | 4.0 | High |
206 | Bluelinea SA | 4.0 | High |
206 | Daihan Scientific Co Ltd | 4.0 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does IGEA Pharma NV have an accelerator or VC vehicle to help deliver innovation?
Does IGEA Pharma NV disclose current and historical energy intensity?
Does IGEA Pharma NV report the average age of the workforce?
Does IGEA Pharma NV reference operational or capital allocation in relation to climate change?
Does IGEA Pharma NV disclose its ethnicity pay gap?
Does IGEA Pharma NV disclose cybersecurity risks?
Does IGEA Pharma NV offer flexible work?
Does IGEA Pharma NV have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does IGEA Pharma NV disclose the number of employees in R&D functions?
Does IGEA Pharma NV conduct supply chain audits?
Does IGEA Pharma NV disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does IGEA Pharma NV conduct 360 degree staff reviews?
Does IGEA Pharma NV disclose the individual responsible for D&I?
Does IGEA Pharma NV disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does IGEA Pharma NV disclose current and / or historical scope 2 emissions?
Does IGEA Pharma NV disclose water use targets?
Does IGEA Pharma NV have careers partnerships with academic institutions?
Did IGEA Pharma NV have a product recall in the last two years?
Does IGEA Pharma NV disclose incidents of discrimination?
Does IGEA Pharma NV allow for Work Councils/Collective Agreements to be formed?
Has IGEA Pharma NV issued a profit warning in the past 24 months?
Does IGEA Pharma NV disclose parental leave metrics?
Does IGEA Pharma NV disclose climate scenario or pathway analysis?
Does IGEA Pharma NV disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does IGEA Pharma NV disclose the pay ratio of women to men?
Does IGEA Pharma NV support suppliers with sustainability related research and development?
Does IGEA Pharma NV disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does IGEA Pharma NV reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is IGEA Pharma NV involved in embryonic stem cell research?
Does IGEA Pharma NV disclose GHG and Air Emissions intensity?
Does IGEA Pharma NV disclose its waste policy?
Does IGEA Pharma NV report according to TCFD requirements?
Does IGEA Pharma NV disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does IGEA Pharma NV disclose energy use targets?
Does IGEA Pharma NV disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does IGEA Pharma NV have a policy relating to cyber security?
Have a different question?
Potential Risks for IGEA Pharma NV
These potential risks are based on the size, segment and geographies of the company.
IGEA Pharma N.V. commercializes health-tech and med-tech products and devices in in the United States and the Netherlands. It offers Alz1, an at-home lab test kit to measure non-bound copper in the blood; dietary supplement products to reduce blood heavy metals content under the Alz1 Tab brand; and COVID19 rapid test for the detection of IgM and IgG SARS-CoV-2 related antibodies. The company also provides dry aerosol generators for air and inanimate environmental surfaces sanitization, as well as air sterilization and purification devices. In addition, it engages in laboratory analysis. The company was incorporated in 2015 and is headquartered in Hoofddorp, the Netherlands.